Featured Insight
Access90: Inflation Reduction Act Insights Series – Patient Affordability: A Key Question Answered
Will the Inflation Reduction Act actually increase drug affordability? Well…it’s complicated. RyanCox, VP, Director, PRECISIONvalue Access Experience Team, outlines the ways it will cut costs—and some watchouts. Learn more in this 90-second video.
Access90: Inflation Reduction Act Insights Series – Impacts on Competition A Key Question Answered
How do you compete against a negotiated drug? As the Inflation Reduction Act challenges current formulary dynamics, PRECISIONvalue expert Erin Lopata has a succinct answer: Prove your value. Learn more in this 90-second video.
Access90: Inflation Reduction Act Insight Series – Payer Controls: Question Two: How Could Manufacturers Adapt Their Approach to Patient Access?
Higher premiums. Increased brand exclusions. Limited treatment populations. Payers may deploy an arsenal of defenses against rising drug costs—and manufacturers should adapt to support patient access. Dominic Galante, Chief Medical Officer PRECISIONvalue, shares thoughts on effective strategies in this short Access90 video.
Access90: Inflation Reduction Act Insights Series – Patient Affordability: A Key Question Answered
Will the Inflation Reduction Act actually increase drug affordability? Well…it’s complicated. RyanCox, VP, Director, PRECISIONvalue Access Experience Team, outlines the ways it will cut costs—and some watchouts. Learn more in this 90-second video.
Access90: Inflation Reduction Act Insights Series – Impacts on Competition A Key Question Answered
How do you compete against a negotiated drug? As the Inflation Reduction Act challenges current formulary dynamics, PRECISIONvalue expert Erin Lopata has a succinct answer: Prove your value. Learn more in this 90-second video.
Access90: Inflation Reduction Act Insight Series – Payer Controls: Question Two: How Could Manufacturers Adapt Their Approach to Patient Access?
Higher premiums. Increased brand exclusions. Limited treatment populations. Payers may deploy an arsenal of defenses against rising drug costs—and manufacturers should adapt to support patient access. Dominic Galante, Chief Medical Officer PRECISIONvalue, shares thoughts on effective strategies in this short Access90 video.
On-Demand Webinar – SDOH and EHR – How are EHR vendors enabling providers’ efforts to close care gaps attributable to SDOH?
In this 1 hour live webinar, Precision experts Thad Nowakowski, Tim Van Aken, and Maureen Hennessey discuss the role that Social Determinants of Health plays in contributing to care gaps, current or proposed quality measures to support health equity, and how the top EHR vendors are enabling end user’s efforts to both capture SDOH variables, and act upon them to close care gaps.
On-Demand Webinar – Trends in Oncology: US Payer Management Considerations for 2022 and Beyond
In the last five years, 83 novel oncology substances have launched - oncology PMPM spend is now the highest among medical benefit categories, with 105% growth anticipated by 2024. As these numbers suggest, oncology is a key area of focus for payers, who are willing to invest resources to support appropriate utilization, but who struggle to keep up with the rapidly evolving science.
On-Demand Webinar – A Novel Data and Analytics-Informed Approach to Launch Excellence
Launching a therapy has become increasingly challenging, with only 34% of launches meeting their year-one goals (Evaluate Pharma, McKinsey). In addition, launches have also become more complex, with additional stakeholders to consider as well as the careful navigation of siloed, enterprise-wide functions and dynamic, fragmented data solutions. Not surprisingly, the path to a successful launch can be very narrow.
A Focus on the Inflation Reduction Act
Curious how the healthcare provisions in the Inflation Reduction Act will impact your business? Start with this booklet by key experts from PRECISIONvalue where 5 experts weigh in on how the Inflation Reduction Act will affect payers in addition to 2023 trends, events, and developments in the payer world. Download the booklet.
White Paper: Achieving Launch Excellence: A Novel Data- and Analytics-Informed Approach
Data and analytics can help drive and inform launch preparations and support efforts to achieve launch excellence through realistic goal-setting and risk mitigation. PRECISIONadvisors works with manufacturers, helping them make key decisions—related to product positioning, go-to-market strategy, and customer engagement across payers, providers, prescribers, and patients—through data- and analytics-driven insights. Learn how an integrated data-driven approach can set realistic goals and de-risk your launch.
White Paper: 2022 and Beyond: How Key Legislative Events Will Impact the Payer Landscape
Interested in learning more about several legislative events shaping the managed care landscape in 2022 and beyond? Check out this insightful white paper, based on our recent webinar, which features insights from PRECISIONvalue’s expert Access Experience Team on various legislative proposals and payers’ potential responses to regulatory changes.
Download Now: Precision October Events Calendar
The October Events Calendar is here! Get all the details on Precision at upcoming conferences, links to upcoming and on-demand webinars, and catch up on our latest thought leadership!
Download Now: Precision September Events Calendar
The October Events Calendar is here! Get all the details on Precision at upcoming conferences, links to upcoming and on-demand webinars, and catch up on our latest thought leadership!
Download Now: Precision June Events Calendar
The June Events Calendar is here! Stay up to date with all of the upcoming Precision conferences, on-demand events and recent thought leadership!
Access90: Inflation Reduction Act Insight Series – Rebates and WAC: A Key Question Answered
When you squeeze a balloon, the air goes somewhere. Same with the cost of drugs. PRECISIONvalue expert Andrew Cournoyer, SVP of the Access Experience Team, explains the anticipated fallout from the Inflation Reduction Act in this 90-second video.
Article: CMS’ strategy is missing the mark: how a focus on prevention can improve health outcomes and contain costs
Cynthia Miller shares her view on how a focus on prevention can improve health outcomes and contain costs in The Pharma Letter.
Medicare Drug Price Negotiation: First 10 Drugs Announced
Download the latest IRA Special Edition Update -- Medicare Drug Price Negotiation: First 10 Drugs Announced. These drugs accounted for $50.5 billion in Medicare Part D spending from June 2022 to May 2023. So what happens next?
Download Now: Precision October Events Calendar
The October Events Calendar is here! Get all the details on Precision at upcoming conferences, links to upcoming and on-demand webinars, and catch up on our latest thought leadership!
Download Now: Precision September Events Calendar
The October Events Calendar is here! Get all the details on Precision at upcoming conferences, links to upcoming and on-demand webinars, and catch up on our latest thought leadership!
Article: The Role of the Pharma Industry in Superseding Outdated Medical Practices
There has been and continues to be a surge in biotech innovation. But a pertinent question arises: how frequently are older, now outdated technologies phased out? Precision's Ross Maclean, Phil Cyr and Ray Roth discuss the reluctance to abandon practices and technologies despite the availability of newer, better alternatives, and list how biopharma can lead the way.
Access90: Inflation Reduction Act Insight Series – Rebates and WAC: A Key Question Answered
When you squeeze a balloon, the air goes somewhere. Same with the cost of drugs. PRECISIONvalue expert Andrew Cournoyer, SVP of the Access Experience Team, explains the anticipated fallout from the Inflation Reduction Act in this 90-second video.
Article: CMS’ strategy is missing the mark: how a focus on prevention can improve health outcomes and contain costs
Cynthia Miller shares her view on how a focus on prevention can improve health outcomes and contain costs in The Pharma Letter.
Medicare Drug Price Negotiation: First 10 Drugs Announced
Download the latest IRA Special Edition Update -- Medicare Drug Price Negotiation: First 10 Drugs Announced. These drugs accounted for $50.5 billion in Medicare Part D spending from June 2022 to May 2023. So what happens next?
Article: The Role of the Pharma Industry in Superseding Outdated Medical Practices
There has been and continues to be a surge in biotech innovation. But a pertinent question arises: how frequently are older, now outdated technologies phased out? Precision's Ross Maclean, Phil Cyr and Ray Roth discuss the reluctance to abandon practices and technologies despite the availability of newer, better alternatives, and list how biopharma can lead the way.
Article: What’s Behind the Slow Uptake of Biosimilars in the US?
Payers have long maintained that the high cost of biologics relative to small-molecule drugs is unsustainable and a threat to their business model. However, a new analysis shows that many plans aren’t yet sold on giving less expensive biosimilars better footing on formularies compared to reference products.
PRECISIONvalue Named a Finalist for the 2023 MM+M awards in the Branded Website for Healthcare Professionals Category
We are excited to announce that PRECISIONvalue has been named a finalist for the 2023 MM+M awards in the Branded Website for Healthcare Professionals category.
Upcoming Webinar: Forging Patient Connections: How Evidence-Based Technologies Are Expanding Access and Adherence
Join us on Thursday, 10/21 @ 1:00 PM ET for this engaging webinar with PQA Quality Forum, featuring PRECISIONvalue's Maureen Hennessey.
On-Demand Webinar: Oncology Care in a Value-Based World
Join us for the webinar Oncology Care in a Value-Based World which will highlight the activities and needs of payers and providers as they strive to deliver high-quality oncology care in a value-based environment. In this presentation, KOLs with market access, population health, and EMR experience will share the ways in which payers and health systems are supporting a value-based approach to oncology through care initiatives, technology, and access to innovative therapies.
On-Demand Webinar: Healthcare Trends in 2021 — How New Clinical and Scientific Innovations Are Shifting the Paradigm
In the first part of our Trends webinar series, our experts discussed how this shift has facilitated novel collaboration between health systems, plans, and pharmaceutical manufacturers and has also led to many new opportunities--but how is the healthcare landscape responding? Join us to learn how new clinical and scientific innovations are shifting the healthcare paradigm.
On-Demand Webinar: Beyond the First 100 Days: Healthcare Policy and Value-Based Care Trends That You Need to Know
Join Precision experts Ross Maclean, Dominic Galante and Maureen Hennessey as they offer insights into trends that are gaining velocity. Watch "Beyond the First 100 Days: Healthcare Policy and Value-Based Care Trends That You Need to Know" on-demand today.
On-demand Webinar: 2020 Social Determinants of Health Series–Assessing and Addressing Social Determinants of Health During a Pandemic
Join us for a webinar featuring KOLs emphasizing applied learnings in the SDOH and population health fields.
On-demand Webinar: Wish I Knew Then What I Know Now–How Cell and Gene Therapies are Reshaping Commercialization Strategies
In this webinar, Carolyn Morgan of PRECISIONeffect moderates an expert panel exploring the challenges of commercializing a cell or gene therapy from industry trailblazers.
White Paper: Oncology Care in a Value-Based World
In this white paper, we explore the results of an exclusive Precision Value & Health survey on how payers and providers are adapting to—and supporting—the delivery of value-based care in an evolving oncology landscape.
White Paper: Engaging With Integrated Delivery Networks to Address the Social Determinants of Health
Increasingly, stakeholders across the healthcare continuum are recognizing the importance of social determinants of health (SDOH) on outcomes and quality of life. In this white paper from Precision’s Maureen Hennessey, we use the results of a 2019 PRECISIONvalue survey and a subsequent 2020 post-onset of COVID-19 survey to evaluate perspectives on SDOH and assess the progress of programs to address SDOH.
PRECISION VALUE & HEALTH NAMES DOUG FULLING PRESIDENT
BETHESDA, MD (January 26, 2023) Precision Value & Health (PVH), today announces that Doug Fulling has joined as President. As the industry leader in delivering complementary, integrated and specialized capabilities across the commercialization continuum, Doug will be accountable for the overall strategy, organizational leadership, financial performance, and next-level growth of this market-leading commercial enterprise. Learn how an integrated data-driven approach can set realistic goals and de-risk your launch.
Miss any of our Recent Precision Value & Health Events? Check out our June Events Calendar
Miss any of our recent Precision Value & Health events? Check out our monthly marketing activities calendar to catch up on-demand, and stay ahead of upcoming dates!
LTEN 2022
Are you attending LTEN June 13- June 15 in San Antonio, Texas? Don't miss our workshop “Biosimilars: Shifting Access Strategies in the Payer and Health Systems Market” on June 15 at at 2:00 pm featuring Precision's Ryan Cox, Erica Gaeta, and Dan Vanderpoel.
LTEN 2021: Customer-Centric Viewpoints: The Value of Experiential Insights in Market Access L&D
Are you attending LTEN 2021, November 8-11? Don't miss the workshop "Customer-Centric Viewpoints: The Value of Experiential Insights in Market Access L&D" on Wednesday, 11/10 at 3:30pm MST | 5:30pm EDT in the Cottonwood 6 room!
AMCP & Precision ADVANCE Corporate Training Program
Cell and gene therapies present tremendous clinical and humanistic opportunity to change the course of disease but also present several unique aspects that differ from more traditional therapies. These differences will impact how innovators develop evidence and manufacture and distribute products. Payers also need to adapt how they assess value, make coverage decisions, and manage reimbursement.
On-Demand Webinar: Oncology Care in a Value-Based World
Join us for the webinar Oncology Care in a Value-Based World which will highlight the activities and needs of payers and providers as they strive to deliver high-quality oncology care in a value-based environment. In this presentation, KOLs with market access, population health, and EMR experience will share the ways in which payers and health systems are supporting a value-based approach to oncology through care initiatives, technology, and access to innovative therapies.
